CONSULTING WITH EXPERTS
UCL is seventh in the world’s top ten universities
(QS Rankings 2015) and the UK’s top-rated
university for research strength (REF 2014). With
over 6,000 academic and research staff, £1 billion
turnover, and students from 150 countries, we are
London’s Global University.
UCL Consultants is a wholly-owned subsidiary of
UCL.
Web: www.uclconsultants.com
UCL Consultants is one of the UK’s leading
providers of academic consultancy. Drawing
on the best of UCL, we can connect you with
critical specialist knowledge and first-class
research facilities, or provide the access to
leading researchers you need. With experience
in working with clients large and small, our
commercial and contractual experience allows
UCL’s academic input to be successfully
integrated into your project.
Email: info@uclconsultants.com
Phone: +44(0)20 7679 9796
UCL consulting capabilities:
Vision and vision disease
Delivered by UCL Consultants Ltd
The UCL Institute of Ophthalmology is
the oldest and largest centre for research
into vision and vision disease in Europe. Colocated with the Moorfields Eye Hospital,
Europe’s leading centre for ophthalmic
treatment, the Institute is at the cutting edge
of translational research that delivers new
therapies, diagnostic tools and preventive
measures to patients suffering from visual
impairment or blinding conditions.
Our accomplishments include:
Specialities - topics:
• recipient of the Queen’s Anniversary Prize
(2011) for excellence in eye and vision
research
• macular degeneration
• first European trials of human stem cells to
treat Stargardt disease
• first clinical trials for gene therapy to treat
Leber’s congenital amaurosis
Services and capabilities offered:
UCL brings value when:
• clinical and pre-clinical trial design support
• designing new clinical products
• drug target reviews
• evaluating potential of investments
• policy and strategy review
• designing policy
• accessibility and rehabilitation advice
• testing and analysis
© 2014 C. Ruhrberg: Mouse retinal vasculature
immunolabelled for fibronectin and isolectin.
• infectious and immune disease of the eye
• retinitis pigmentosa
• angiogenesis
• genetics and genetic screening
• home to one of England’s National
Specialist Ophthalmic Pathology Service
labs
Specialities - methods:
• awarded £26.5 million by the NIHR
for a Biomedical Research Centre for
Ophthalmology
• imaging
• pioneer of nanoparticle delivery system to
replace eye injections
• briefings on the current state of the field
• bespoke training
• developed the “twinkle” test for screening
for macular degeneration
• glaucoma
• gene and stem cell therapy
• rehabilitation and visual behaviour
• pathology
• MHRA-accredited GMP facility for stem cell
culture